angiotensin ii has been researched along with Experimental Mammary Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrera, MP; Dueñas, B; García, MJ; Martínez-Martos, JM; Mayas, MD; Ramírez-Expósito, MJ; Valenzuela, MT | 1 |
| Levy, J; Marbach, M; Radian, S; Sharoni, Y; Teuerstein, I | 1 |
| Lao, X; Nalcioglu, O; Roth, GM; Samoszuk, MK; Su, MY; Wang, Z | 1 |
| Clifton, KH; Jirtle, R; Rankin, JH | 2 |
| Levy, J; Radian, S; Sharoni, Y | 1 |
| Baba, T; Taniguchi, S | 1 |
| Brainard, J | 1 |
8 other study(ies) available for angiotensin ii and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Renin-angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea.
Topics: Alkylating Agents; Aminopeptidases; Angiotensin II; Animals; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Pineal Gland; Rats; Renin-Angiotensin System | 2006 |
Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiotensin II; Animals; Cations, Divalent; Cell Membrane; Cyclic AMP; Female; Flavonoids; Kinetics; Mammary Neoplasms, Experimental; Peptide Fragments; Phosphopeptides; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quercetin; Rats | 1984 |
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Flow Velocity; Capillary Permeability; Cell Transplantation; Contrast Media; Female; Gadolinium DTPA; Hydralazine; Kidney; Liver; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Muscle, Skeletal; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Effects of several vasoactive drugs on the vascular resistance of MT-W9B tumors in W/Fu rats.
Topics: Angiotensin II; Animals; Female; Infusions, Parenteral; Injections, Intravenous; Isoproterenol; Mammary Neoplasms, Experimental; Neoplasms; Norepinephrine; Radiography; Rats; Rats, Inbred WF; Vascular Resistance | 1978 |
Effect of x-irradiation of tumour bed on tumour blood flow and vascular response to drugs.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Female; Isoproterenol; Lung; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Norepinephrine; Rats; Skin | 1978 |
Membranal tyrosine protein kinase activity (but not cAMP-dependent protein kinase activity) is associated with growth of rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiotensin II; Animals; Cell Division; Cyclic AMP; Female; Mammary Neoplasms, Experimental; Membranes; Oligopeptides; Perphenazine; Prolactin; Protein Kinases; Protein-Tyrosine Kinases; Quercetin; Rats | 1985 |
[Improvement of cancer therapy by angiotensin II-induced hypertension chemotherapy].
Topics: Aminophylline; Angiotensin II; Animals; Blood Pressure; Carbazilquinone; Cisplatin; Drug Therapy, Combination; Female; Mammary Neoplasms, Experimental; Mice | 1987 |
Treatment of malignant tumors.
Topics: Angiotensin II; Animals; Mammary Neoplasms, Experimental; Mice | 1966 |